ePIPE Team Awarded U.S. Patent - for application of an 'in-place' coating to protect underground pipes against water loss due to leaks
Pipe Restoration Technologies, LLC, (PRT) makers of the ePIPE®, Lead-Free, Leak-Free™ and LeadSmart® product lines, announced that it has been granted U.S. patent #9744561. This patent is related to the ePIPE system of in-place pipe restoration which providesprotection to underground pipes against leaks and harmful lead and copper leaching.
|
|
“ePIPE is providing superior solutions in response to real-time issues of providing protection against leaks and reducing the leaching of toxic metals like lead and copper from underground pressurized water supply pipes. With some utilities reporting water loss due to leaks at 35% or greater our solution provides a significant opportunity to address water loss”, said Pipe Restoration Technologies CEO Larry Gillanders. “ePIPE applicators save their customers time and money with ePIPE’s fast installation.Protecting underground water carrying pipes including lead service lines (LSLs) can be completed in under four hours per line and often with no excavation on the home owner’s property.”
Pipes protected with ePIPE reduce the loss of water and reduce the leaching of toxic lead and copper into drinking water to well below U.S. Environmental Protection Agency (EPA) and World Health Organization (WHO) cut-off levels. Pipes from as small as 1/2'' in diameter can be protected in-place using the patented ePIPE system and materials.
|
|
August 30, 2017
Topic Area:
Press Release
Recent Posts
Manufacturers discuss what trends are shaping the future of backup power systems in healthcare.
Infection control is essential to protecting both patients and staff from contracting measles.
It also announced it's in the early stages of planning a rebuild and expansion of its Westminster Medical Offices.
The new facility will provide internal medicine, family medicine, pediatrics, as well as lab and imaging services.
Advantages of probiotic cleaning include fewer resistant genes and cost savings through decreased antibiotic use.